This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...

AM (IST) on Wednesday, 0.62 per cent from previous close. The stock quoted a 52-week low price of Rs 1411.15 and a high of Rs ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD 36 million in the U.S. (IQVIA MAT November 2024) ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Mumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, ...